Rita Dost

462 total citations
15 papers, 390 citations indexed

About

Rita Dost is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Rita Dost has authored 15 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in Rita Dost's work include Neuroscience and Neuropharmacology Research (9 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Ion channel regulation and function (3 papers). Rita Dost is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Ion channel regulation and function (3 papers). Rita Dost collaborates with scholars based in Germany, Finland and United Kingdom. Rita Dost's co-authors include Chris Rundfeldt, Barbara Langen, A Rostock, Ute Egerland, Klaus Unverferth, Hans‐Joachim Lankau, Christian Grunwald, Hans Stange, Hans–Jörg Hofmann and Thomas Kronbach and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Rita Dost

15 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Dost Germany 9 191 184 90 84 48 15 390
Richard G. Boles United States 5 261 1.4× 304 1.7× 45 0.5× 42 0.5× 37 0.8× 8 461
Judit Laszy Hungary 10 184 1.0× 275 1.5× 75 0.8× 179 2.1× 15 0.3× 18 528
Shengming Huang United States 13 258 1.4× 279 1.5× 59 0.7× 33 0.4× 27 0.6× 24 540
Nicholas Mallard United Kingdom 9 263 1.4× 273 1.5× 36 0.4× 32 0.4× 17 0.4× 11 548
Stephan Hjorth Sweden 15 272 1.4× 346 1.9× 75 0.8× 44 0.5× 12 0.3× 22 540
Jeanette Watson United Kingdom 8 289 1.5× 319 1.7× 26 0.3× 81 1.0× 13 0.3× 8 502
Nikola Jancovski Australia 11 181 0.9× 100 0.5× 29 0.3× 76 0.9× 112 2.3× 19 455
Carole A. Wilmot United States 11 160 0.8× 270 1.5× 43 0.5× 107 1.3× 11 0.2× 16 466
Zsolt Némethy Hungary 10 263 1.4× 265 1.4× 41 0.5× 229 2.7× 16 0.3× 20 638
Peter Heusler France 13 273 1.4× 316 1.7× 33 0.4× 89 1.1× 14 0.3× 23 522

Countries citing papers authored by Rita Dost

Since Specialization
Citations

This map shows the geographic impact of Rita Dost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Dost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Dost more than expected).

Fields of papers citing papers by Rita Dost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Dost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Dost. The network helps show where Rita Dost may publish in the future.

Co-authorship network of co-authors of Rita Dost

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Dost. A scholar is included among the top collaborators of Rita Dost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Dost. Rita Dost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nissinen, Liisa, Barbara Langen, Rita Dost, et al.. (2015). Sulfonamide inhibitors of α2β1 integrin reveal the essential role of collagen receptors in in vivo models of inflammation. Pharmacology Research & Perspectives. 3(3). e00146–e00146. 7 indexed citations
2.
Schwake, Michael, et al.. (2012). The new KCNQ2 activator 4‐Chlor‐N‐(6‐chlor‐pyridin‐3‐yl)‐benzamid displays anticonvulsant potential. British Journal of Pharmacology. 168(5). 1182–1200. 16 indexed citations
3.
Langen, Barbara, et al.. (2011). Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test. Psychopharmacology. 221(2). 249–259. 29 indexed citations
4.
5.
Langen, Barbara & Rita Dost. (2010). Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists. ADHD Attention Deficit and Hyperactivity Disorders. 3(1). 1–12. 59 indexed citations
6.
Lankau, Hans‐Joachim, Klaus Unverferth, Christian Grunwald, et al.. (2007). New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity. European Journal of Medicinal Chemistry. 42(6). 873–879. 64 indexed citations
7.
Lankau, Hans‐Joachim, Klaus Unverferth, Christian Grunwald, et al.. (2007). New GABA‐Modulating 1,2,4‐Oxadiazole Derivatives and Their Anticonvulsant Activity.. ChemInform. 38(42). 2 indexed citations
8.
Grunwald, Christian, Chris Rundfeldt, Hans‐Joachim Lankau, et al.. (2006). Synthesis, Pharmacology, and Structure−Activity Relationships of Novel Imidazolones and Pyrrolones as Modulators of GABAAReceptors. Journal of Medicinal Chemistry. 49(6). 1855–1866. 39 indexed citations
9.
10.
Langen, Barbara, Rita Dost, & Chris Rundfeldt. (2005). Antipsychotic effect of the alpha–3 subunit selective benzodiazepine agonist ELB139 in rats. Pharmacopsychiatry. 38(5). 1 indexed citations
11.
Dost, Rita, Barbara Langen, & Chris Rundfeldt. (2005). ELB139, an alpha–3 subunit selective benzodiazepine agonist, does not induce tolerance in animal models for anxiety and epilepsy. Pharmacopsychiatry. 38(5). 3 indexed citations
12.
Dost, Rita, A Rostock, & Chris Rundfeldt. (2004). The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(4). 382–390. 67 indexed citations
13.
14.
Rostock, A, C. Tober, Rita Dost, et al.. (1998). AWD-131-138. Drugs of the Future. 23(3). 253–253. 18 indexed citations
15.
Rostock, A, et al.. (1998). AWD 131???138. Behavioural Pharmacology. 9(1). S79–S79. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard G. Boles Breakdown of academic impact, for papers by Judit Laszy Breakdown of academic impact, for papers by Shengming Huang Breakdown of academic impact, for papers by Nicholas Mallard Breakdown of academic impact, for papers by Stephan Hjorth Breakdown of academic impact, for papers by Jeanette Watson Breakdown of academic impact, for papers by Nikola Jancovski Breakdown of academic impact, for papers by Carole A. Wilmot Breakdown of academic impact, for papers by Zsolt Némethy Breakdown of academic impact, for papers by Peter Heusler
Rankless by CCL
2026